Search company, investor...

Stage

Unattributed VC | Alive

Total Raised

$1M

Last Raised

$1M | 13 yrs ago

About BioAtlantis

BioAtlantis Ltd., a biotech company, engages in the development and production of nutraceutical ingredients for the plant, human, and animal markets in European Union, Asia, and South America.

Headquarters Location

Ireland

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

BioAtlantis Patents

BioAtlantis has filed 8 patents.

The 3 most popular patent topics include:

  • Dietary supplements
  • Food additives
  • Nutrition
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/30/2018

2/21/2023

Acetylcholinesterase inhibitors, Organophosphate insecticides, Agricultural pest nematodes, Tylenchida, Insecticides

Grant

Application Date

8/30/2018

Grant Date

2/21/2023

Title

Related Topics

Acetylcholinesterase inhibitors, Organophosphate insecticides, Agricultural pest nematodes, Tylenchida, Insecticides

Status

Grant

Latest BioAtlantis News

JHI and BioAtlantis to develop molecular priming technology

Jun 20, 2023

James Hutton Institute THE James Hutton Institute is collaborating with leading research groups and industrial collaborator BioAtlantis in a new European research project called "CropPrime." With EU Horizon funding of up to €1 million confirmed, CropPrime will develop "Molecular Priming" technologies, which will enhance crop yield under stressful conditions caused by climate change. The project will primarily focus on developing novel technologies to improve crop tolerance to stresses associated with climate change. One important aspect of the project will be the identification of natural compounds found in "plant biostimulant products" (which trigger natural plant processes that enhance nutrient use efficiency), derived from marine algae such as seaweed, produced by BioAtlantis, based in County Kerry, Ireland. Additionally, the project will work on developing RNA (similar to DNA)-based fungicides to reduce fungal infections in crops. The overall goal of this research is to develop sustainable agri-tech products to help crop growers protect and enhance their crops against adverse weather conditions such as drought, heat, cold, and water-logging, which are becoming more frequent due to climate change. The Hutton along with its project partners, will investigate the molecular mechanisms underlying plant stress and how these relate to the physiological processes that support crop resilience. The project consortium brings together expertise in plant systems biology, chemistry, genetics, and biostimulant technology from research institutions in Europe, Africa, and South America. By pooling their efforts, the consortium aims to provide sustainable solutions for crop protection to growers. Senior biochemist and plant physiologist at The James Hutton Institute, Dr Robert Hancock, said: “This ambitious endeavour aligns perfectly with our mission to drive innovative solutions for sustainable agriculture in the face of climate change. “By harnessing the power of 'Molecular Priming' technologies and leveraging natural compounds derived from marine algae, we aim to enhance crop resilience and protect against the increasing stresses brought about by adverse weather conditions. The CropPrime project exemplifies the power of international collaboration and knowledge exchange, and we are excited to contribute to the global impact of this research. Together, we can pave the way for a more resilient and productive future in agriculture."

BioAtlantis Frequently Asked Questions (FAQ)

  • What is BioAtlantis's latest funding round?

    BioAtlantis's latest funding round is Unattributed VC.

  • How much did BioAtlantis raise?

    BioAtlantis raised a total of $1M.

  • Who are the investors of BioAtlantis?

    Investors of BioAtlantis include Bank of Ireland Asset Management.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.